Vioxx

We are taking steps which follow the certification of the Vioxx Class Action for Canada. An order was made by Mr. Justice Cullity in February 2010 after the finalization of the dismissal by the Courts of the final appeals from the certification granted by the court.

We reviewed each of our files and letters were sent by mail to all of our clients (except in Quebec and Saskatchewan) advising that of a June 30, 2010 deadline for the receipt of any and all forms opting out of the class action. Most clients responded and we sent opt-out forms to the class action administrator.  Where the person has opted out they are required to proceed with an individual claim in court which would not be limited to the amounts for class action settlement once reached. An individual case would carry with it the risk of what outcome will be reached in their case.  There is also a risk for the person claiming to be responsible for paying Merck’s legal costs in the event their claim is not successful.  Those who stay in the class action will have no responsibility for any legal costs but if and when the class action settles they would be required to accept an amount determined by a formula for compensation in the class action as approved by the Court.

If you chose to stay in the Class Action we will continue to represent you and do the necessary work to see that you receive the maximum entitlement under the circumstances of your case for any future settlement.  The cases we recommended for opting out are ones with more serious heart attack or stroke injuries, work disability and loss of income, significant regular Vioxx use (including use at the time of the event) and fewest other cardiac risk or other negative factors (eg. smoking, family or personal medical history, age, weight).  For those cases there will be close scrutiny by Merck and its lawyers of the strength of the case, so that a claim that may end up paid through the class action may not be strong enough to succeed on an individual basis.  We are preparing court claims for the individual cases and it is not known how far those cases will go individually in the court process before they are resolved. There have been no significant developments to report this summer yet…

For now:

1. Please send us a note by mail, fax or email to confirm all of your current contact information unless you have done so recently and there is no change. Do not put personal information into comments you may wish to make here at our website. The postings are available for anyone to see.

2.  Please send us any prescription records or other documentation of Vioxx use that you have not already sent us.

3.  Please send us any updates as to medical or work disability condition changes from before and any new health issues related or not.

4.  Please send us any Death Certificate, Will, or Estate Probate documentation you have not sent us before if the Vioxx user is deceased. We will need to get instructions from the Estate Executor if there is one. Be aware that family members are bound by the decision of the injured party and can not split claims between the class action and outside of the class action.  Families should begin to discuss this and come to a decision together.

5.  We welcome general questions or comments which will be posted at this website. For ANY specific personal case questions call our office or email: miskinlaw@yahoo.com

WE HAVE BEEN WAITING A LONG TIME FOR THIS STAGE IN THE VIOXX CLASS ACTION CLAIM.  THIS DOES NOT MEAN THERE IS ANY SETTLEMENT BUT WE HAVE MOVED A STEP CLOSER TO RESOLVING CANADIAN VIOXX CLAIMS. THANKS TO THOSE WHO HAVE RETURNED THEIR ELECTION FORMS.

In Canada all claimants (outside of Quebec and Saskatchewan) had to decide before June 30, 2010 whether to accept the class action as the basis for their compensation or to opt out and seek compensation based on their individual case. We advised each of our clients and guided them through that decision making process.  Read our article at this website titled: “Attention Vioxx Clients”. If you have a serious Vioxx injury (to yourself or a family member) you need legal advice right away and should have a lawyer to represent you and help you decide what to do.  If you are represented by another law firm you should have checked by now with that law firm about your options and their advice for your claim. If you have done nothing you are part of the Class Action and will have to accept the compensation that it may or may not give you.  If you opted out by the June 30 deadline you may get more compensation depending on your case but you also will face a greater risk.

At some point a business decision will be made by Merck to settle claims outside the US, and Canada may or may not be early on Merck’s settlement agenda.  Merck can not be forced to settle and the road to trial is still a long one. Extreme patience is still required. The following paragraphs set out the history of the Vioxx case for Canadians until now:

Vioxx was a very popular, profitable and highly promoted anti-inflammatory drug manufactured by Merck and rushed to market in 1999 to compete with Pfizer’s similar drug Celebrex. When evidence, originally suppressed by Merck, came out about cardiac dangers the drug was recalled from the market September 30, 2004. At that time our firm sought out individual clients to make claims against Merck. Many of these claims are for fatal incidents where we represent the families of Vioxx users who died after using the drug. Across Canada a number of “class action” claims were issued by lawyers. Most of those lawyers who each act for a “representative plaintiff” are united in a national coalition with the primary court proceedings in Toronto, Ontario. We have worked with the class action lawyers to assist in showing the strength of the claims by Canadians related to Vioxx, but our focus has been on individual clients rather than participating directly in the class action Court proceedings in Canada. Claims were brought for some of our clients in the New Jersey court but those claims were not allowed to continue as a term for settlement of American claims.
Claims against the manufacturer Merck were disputed hotly and there were mixed trial results in the United States before a settlement was reached. Some cases were in the US Federal Court and some were tried in individual state courts. There are a number of unusual situations which were not considered when the American settlement was agreed upon and there is some fine tuning to do before it is completed. This stage is likely to end before settlements in Canada and other countries will be considered by Merck. There has been a settlement this year of an American class action case to reimburse those who paid for Vioxx prescriptions but that does not affect individual injury claims. In the United States injury claims are not dealt with by class action. The Canadian class action in Ontario for people injured by Vioxx use was certified in 2008 but that was delayed by appeal in Ontario and to the Supreme Court of Canada until late 2009. Merck continues efforts to delay the proceedings until they are ready to talk. We expect to be in direct talks with Merck when that time comes. We are hoping this will still happen this year, 2010 and we are continuing our work towards that with our file preparation. With Merck there are a huge number of claims all over the world and the first three years after recall of the drug were ones where Merck denied any responsibility for the effects of Vioxx. This denial remains in effect in Canada but can not logically continue as U.S. cases settle. Recently, in Australia,  Merck lost the first Vioxx trial outside of the United States. We are still looking at pursuing individual settlements for many of our clients with others being part of a class action settlement. We will again be contacting each of our clients when it looks like there will be a Canadian settlement. To date there have been no developments related to possible Canadian settlement and our approaches to the company have been rejected as premature. An appeal of class action certification was finally dismissed.  On October 22 the Supreme Court of Canada put an end to Merck’s attempt to stall the class action due to inter-provincial conflict and confirmed the rejection of a separate Saskatchewan national claim by that province’s appeal court.  The Ontario Divisional Court finally decided to dismiss Merck’s last appeal and deny further leave (permission) to Appeal in a December 7th decision by Madam Justice Denise Bellamy. That decision was not reported in the news and there is still little general knowledge that certification appeals are over.  On February 10, 2010 Mr. Justice Cullity updated the procedural orders related to the certified class action and we now have until June 30 to deliver notices for individual claims opting out of the class action.  This order was formally issued by the Court on March 5, 2010.  Only one newspaper notice was ordered to be given which was in the Globe and Mail newspaper February 27, 2010.  Most people with claims still have no idea that the Class Action is proceeding and that an important decision must be made and filed for individual cases by the end of June 2010.

We are working on our own strategy for settlement and for the procedure for advancing individual claims now that the class action certification is complete.  The lawyers for Merck in Canada appear to have clear instructions to simply continue to focus on delaying the class action proceedings in court for now.  We are proceeding with several cases opted out of the class action and are working on issuing court claims in several provinces. Some of our discussions and our strategy mut be kept confidential as this website is accessible to anyone. You may still contact our firm for representation now if you believe you have a Vioxx injury claim for yourself or a family member. Murray Miskin, July 1,2010

A QUOTE: “We try to remember that medicine is for the patient. We try never to forget that medicine is for the people. It is not for the profits. The profits follow, and if we have remembered that, they have never failed to appear. The better we have remembered it, the larger they have been.” George W. Merck II (1935)

Yaz and Yasmin are dangerous

Yasmin® and Yaz® are two similar birth control products that Bayer manufactures, markets, and distributes containing a fourth-generation progestin called drospirenone.  These leading products have been found to have very serious adverse affects and we caution women to study that carefully before beginning use of them.  The products are marketed by Bayer to young women as effective and as having other benefits like helping with mild depression and acne control as well.

Yaz and Yasmin can cause dehydration in the body which causes an increase in the potassium levels (hyperkalemia) and a decrease in the sodium levels (hyponatremia) in the body.  As potassium acts as a key control in cardiac rhythm, this imbalance can cause hyperkalemia arrhythmias, which, in turn can cause blood clots and thrombotic events such as stroke or deep vein thrombosis, pulmonary embolism, or heart attack. Dehydration is also a risk factor for kidney stones and gallbladder disease.
While other birth control pills can cause thrombotic events, the cause of those effects are from the estrogen side of the equation. The thrombotic effects of Yaz and Yasmin are from the progesterin side. While it has long been accepted that high estrogen levels can cause these adverse events, Yaz/Yasmin/Ocella have been marketed as having low estrogen levels, thereby having a lower risk for thrombotic events. There have been several studies that have called this into question.

Our firm now has clients with serious injuries and we are involved in court class action proceedings related to Yaz and Yasmin. Most of our clients have gall bladder issues but some have blood clots and cardiac problems.  A great number of individual court cases are proceeding in the United States and our firm has been retained in Canada to represent Canadians across the country with problems from these drugs.  We are working to get maximum compensation for each of our clients  with the class action and in separate law suits and  possibly in the US courts.  If you believe that you have suffered harm from Yaz or Yasmin contact Murray Miskin directly by email to miskinlaw@yahoo.com or call Anna at Extension 118 at our office.  We will send you our detailed questionnaire and assess whether you have a case once we have your detailed answers back. If we think you have a case we will represent you on a contingency fee basis so there will be no expense or risk to you.